Rchr
J-GLOBAL ID:201101087603597669   Update date: Sep. 21, 2021

Sato Akinori

サトウ アキノリ | Sato Akinori
Affiliation and department:
Homepage URL  (1): https://www.researchgate.net/profile/Akinori_Sato6
Research field  (4): Education - general ,  Molecular biology ,  Tumor biology ,  Urology
Research keywords  (30): 医学教育 ,  HIVプロテアーゼ阻害薬 ,  ritonavir ,  vorinostat ,  SAHA ,  プロテアソーム阻害薬 ,  HDAC阻害薬 ,  ER stress ,  proteasome inhibitor ,  HDAC inhibitor ,  urology ,  cell cycle ,  apoptosis ,  combination therapy ,  bladder cancer ,  prostate cancer ,  renal cancer ,  protein ubiquitination ,  histone acetylation ,  細胞周期 ,  アポトーシス ,  IAP蛋白 ,  併用療法 ,  膀胱癌 ,  腎癌 ,  小胞体ストレス ,  ヒストンアセチル化 ,  蛋白ユビキチン化 ,  泌尿器科癌 ,  前立腺癌
Research theme for competitive and other funds  (15):
  • 2018 - 2021 ヒストン脱アセチル化酵素阻害薬の作用増強による膀胱癌新規治療法の開発
  • 2016 - 2019 特殊感染症に対する対応能力の向上と質的迅速診断の確立並びに新規治療法の開発
  • 2014 - 2017 小胞体ストレス誘導による膀胱癌新規治療法の開発
  • 2014 - 2015 進行腎癌に対する新規治療の開発
  • 2011 - 2013 前立腺癌に対するユビキチン化蛋白蓄積を介した新規治療法の開発
Show all
Papers (103):
  • Okubo K, Miyai K, Kato K, Asano T, Sato A. Simvastatin-romidepsin combination kills bladder cancer cells synergistically. Translational Oncology. 2021. 14. 9. 101154
  • Okubo K, Isono M, Asano T, Reßing N, Schulz WA, Hansen FK, Sato A. Ubiquitin-proteasome system is a promising target for killing cisplatin-resistant bladder cancer cells. Anticancer Research. 2021. 41. 6. 2901-2912
  • Isono M, Okubo K, Asano T, Sato A. Inhibition of checkpoint kinase 1 potentiates anticancer activity of gemcitabine in bladder cancer cells. Scientific Reports. 2021. 11. 1. 10181
  • Okubo K, Hamabe F, Miyai K, Isono M, Shinmoto H, Sato A. Prostate cancer recurrence mimicking invasive urothelial cancer of the bladder. Urology Case Reports. 2020. 33. 101421
  • Okubo K, Isono M, Miyai K, Asano T, Sato A. Fluvastatin potentiates anticancer activity of vorinostat in renal cancer cells. Cancer Science. 2020. 111. 1. 112-126
more...
MISC (242):
Lectures and oral presentations  (100):
  • オンデマンド講義の問題点克服を目指した新しい遠隔講義法の実践
    (第53回日本医学教育学会大会 2021)
  • Ritonavir, a potent inhibitor of CYP3A4, enhances the anticancer effects of panobinostat in bladder cancer cells
    (The 35th European Association of Urology Congress (Virtual) 2020)
  • Vorinostat and ixazomib cause bladder cancer apoptosis synergistically by inducing endoplasmic reticulum stress
    (The 35th European Association of Urology Congress (Virtual) 2020)
  • Simvastatin augments anticancer activity of romidepsin in bladder cancer cells by causing AMP-activated protein kinase activation and histone acetylation
    (The 35th European Association of Urology Congress (Virtual) 2020)
  • Ritonavir and oprozomib inhibit renal cancer growth by inducing endoplasmic reticulum stress
    (The 115th American Urological Association Annual Meeting (Virtual) 2020)
more...
Education (2):
  • 1995 - Keio University
  • 1989 - 慶應義塾高等学校卒業
Professional career (1):
  • 博士(医学) (慶應義塾大学)
Work history (14):
  • 2021/05 - 防衛医科大学校教務部医学教育開発官付 併任
  • 2015/04 - 防衛医科大学校医学教育部医学科講師(泌尿器科学)
  • 2011/10 - 防衛医科大学校指定講師(学内講師)
  • 2006/12 - Heinrich Heine大学(ドイツ連邦共和国)客員研究員
  • 2004/06 - 防衛医科大学校医学教育部医学科助手(泌尿器科学)
Show all
Committee career (10):
  • 2021/07 - 現在 Translational Oncology Editorial Board
  • 2021/07 - 現在 Biomedicines Editorial Board
  • 2020/09 - 現在 Member of the World Academy of Sciences (WAS)
  • 2020/09 - 現在 World Academy of Sciences Journal Editorial Board
  • 2020/04 - 現在 Molecular Medicine Reports Editorial Board
Show all
Awards (73):
  • 2021/04 - Translational Cancer Research Reviewer of the Month
  • 2021/04 - Translational Andrology and Urology Reviewer of the Month
  • 2020/03 - 一般財団法人鈴木泌尿器医学振興財団 研究助成
  • 2019/11 - Excellence in Reviewing (Oncol Lett) - 2
  • 2019/11 - Excellence in Reviewing (Oncol Lett) - 1
Show all
Association Membership(s) (8):
THE JAPAN SOCIETY FOR MEDICAL EDUCATION ,  GERMAN-JAPANESE CONFEDERATION OF UROLOGY ,  THE JAPANESE ASSOCIATION FOR MOLECULAR TARGET THERAPY OF CANCER ,  JAPANESE SOCIETY FOR MOLECULAR AND CELLULAR UROLOGY ,  EUROPEAN ASSOCIATION OF UROLOGY ,  THE JAPANESE CANCER ASSOCIATION ,  THE JAPANESE UROLOGICAL ASSOCIATION ,  日本保健医療福祉連携教育学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page